XML 33 R5.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands
6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Cash flows from operating activities:    
Net loss $ (1,302) $ (3,774)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Change in allowance for doubtful accounts (46) (232)
Depreciation and amortization 2,550 2,301
Accretion on note payable - related party 66 66
Amortization of debt discount for the 6% secured promissory note issued in connection with the acquisition of StarTrak 3  
Loss on disposition of other investment in Alanco 305  
Stock-based compensation 659 1,024
Foreign exchange (gains) losses (10) 83
Amortization of premium on marketable securities 801 384
Deferred income taxes 65  
Gain on settlement of vendor liabilities   (220)
Dividend received in common stock from other investment (84)  
Impairment charge-net assets held for sale   3,261
Changes in operating assets and liabilities:    
Accounts receivable (2,223) (621)
Inventories 119 11
Prepaid expenses and other assets (24) (50)
Accounts payable and accrued liabilities (315) (803)
Deferred revenue (85) (359)
Other liabilities (61)  
Net cash provided by operating activities of continuing operations 418 1,071
Net cash provided by operating activities of discontinued operations   23
Net cash provided by operating activities 418 1,094
Cash flows from investing activities:    
Capital expenditures (3,844) (2,655)
Purchases of marketable securities (47,497) (91,800)
Proceeds from maturities of marketable securities 59,810 45,070
Purchase of other investment   (1,356)
Acquisition of net assets of StarTrak, net of cash acquired of $321 (1,876)  
Change in restricted cash 810 (50)
Net cash provided by (used in) investing activities of continuing operations 7,403 (50,791)
Cash flows from financing activities:    
Principal payment of note payable (200)  
Payment upon exercise of SARs (24)  
Net cash used in financing activities (224)  
Effect of exchange rate changes on cash and cash equivalents 95 34
Net increase (decrease) in cash and cash equivalents 7,692 (49,663)
Cash and cash equivalents:    
Beginning of period 17,026 65,292
End of period 24,718 15,629
Noncash investing and financing activities:    
Capital expenditures incurred not yet paid 806 1,260
Stock-based compensation included in capital expenditures 29 14
Accounts receivable exchanged and deferred credit issued as part of consideration for other investment   894
Gateway and components recorded in inventory in prior years and used for construction under satellite network and other equipment 53 129
Common stock issued as a form of payment for bonus 125  
6% secured promissory note issued in connection with the acquisition of StarTrak 3,812  
Series A convertible preferred stock issued in connection with the acquisition of StarTrak 1,834  
Common stock issued in connection with the acquisition of StarTrak 8,349  
Cost method investment in Alanco delivered back to Alanco in connection with the acquisition of StarTrak $ 2,050